Celldex Therapeutics, Inc. (CLDX) Operating margin 2016–2025
Celldex Therapeutics, Inc. (CLDX) operating margin by fiscal year — reported operating income divided by reported revenue.
-18599.8%FY2025 · since FY2016: -1958.7% → -18599.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18599.8% | -15820.9 pp |
| FY2024 | -2778.9% | -533.6 pp |
| FY2023 | -2245.3% | +2643.7 pp |
| FY2022 | -4889.0% | -3357.2 pp |
| FY2021 | -1531.8% | -677.7 pp |
| FY2020 | -854.1% | +686.1 pp |
| FY2019 | -1540.2% | +99.9 pp |
| FY2018 | -1640.1% | -686.5 pp |
| FY2017 | -953.7% | +1005.0 pp |
| FY2016 | -1958.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice